Status:
TERMINATED
Treating Alzheimer's and Dementia With D-ribose
Lead Sponsor:
Practitioners Alliance Network
Conditions:
Alzheimers
Dementia
Eligibility:
All Genders
Phase:
NA
Brief Summary
To study the effectiveness of d-ribose in treating Alzheimer's and Dementia
Detailed Description
Clinical experience and the pathophysiology of Alzheimer's, including neuronal insulin resistance, suggests that ribose improves clinical outcomes. This study will add ribose 5 gm 3 X day for 8 weeks ...
Eligibility Criteria
Inclusion
- A diagnosis of Alzheimer's and/or dementia with a Mini Mental Status Exam ( MMSE) score over 12 or being ambulatory and able to travel outside the home with assistance.
- Must have a caregiver living with them.
Exclusion
- Overt and severe causes of secondary dementia such as metastatic brain cancers, or severe overt infectious encephalopathies or severe autoimmune illness.
- Also, severe life threatening illnesses which would make them unlikely to be alive after 6-12 months.
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2017
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT02260141
Start Date
September 1 2014
End Date
October 1 2017
Last Update
May 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PAN
Kailua, Hawaii, United States, 96740